{"database": "lobbying", "table": "lobbying_activities", "rows": [[1550411, "e34a05e1-77ac-4ce5-b17b-6ff506fc423e", "Q2", "HEARTLAND SOLUTIONS GROUP, INC.", 312133, "ZEBRA TECHNOLOGIES CORPORATION", 2014, "second_quarter", "PHA", "Any and all issues related to labeling of generic drugs.", "HOUSE OF REPRESENTATIVES,SENATE", 8950, null, 0, 0, "2014-07-14T16:48:11.947000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1550411"], "units": {}, "query_ms": 0.40068296948447824, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}